These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 1732950
1. Lymphoma: predictive value of Ga-67 scintigraphy after treatment. Front D, Ben-Haim S, Israel O, Epelbaum R, Haim N, Even-Sapir E, Kolodny GM, Robinson E. Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950 [Abstract] [Full Text] [Related]
2. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment. Israel O, Mekel M, Bar-Shalom R, Epelbaum R, Hermony N, Haim N, Dann EJ, Frenkel A, Ben-Arush M, Gaitini D. J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366 [Abstract] [Full Text] [Related]
3. Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma. Israel O, Mor M, Epelbaum R, Frenkel A, Haim N, Dann EJ, Gaitini D, Bar-Shalom R, Kolodny GM, Front D. Cancer; 2002 Feb 15; 94(4):873-8. PubMed ID: 11920453 [Abstract] [Full Text] [Related]
4. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy. Front D, Bar-Shalom R, Mor M, Haim N, Epelbaum R, Frenkel A, Gaitini D, Kolodny GM, Israel O. Radiology; 2000 Jan 15; 214(1):253-7. PubMed ID: 10644133 [Abstract] [Full Text] [Related]
5. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. Vose JM, Bierman PJ, Anderson JR, Harrison KA, Dalrymple GV, Byar K, Kessinger A, Armitage JO. J Clin Oncol; 1996 Sep 15; 14(9):2473-9. PubMed ID: 8823325 [Abstract] [Full Text] [Related]
6. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Yang CC, Sun SS, Lin CC, Kao CH, Lee CC. Anticancer Res; 2001 Sep 15; 21(5):3695-8. PubMed ID: 11848545 [Abstract] [Full Text] [Related]
7. Ga-67 SPECT before and after treatment of lymphoma. Front D, Israel O, Epelbaum R, Ben Haim S, Sapir EE, Jerushalmi J, Kolodny GM, Robinson E. Radiology; 1990 May 15; 175(2):515-9. PubMed ID: 2183289 [Abstract] [Full Text] [Related]
8. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value. Castellani MR, Cefalo G, Terenziani M, Aliberti G, Maccauro M, Alessi A, Villano C, Bombardieri E. Q J Nucl Med; 2003 Mar 15; 47(1):22-30. PubMed ID: 12714951 [Abstract] [Full Text] [Related]
9. The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma. Tuli MM, Al-Shemmari SH, Ameen RM, Al-Muhanadi S, Al-Huda FA, Ballani N, Khoshi M, Al-Enezi F, Bajciova V, Mottl H. Clin Lymphoma; 2004 Jun 15; 5(1):56-61. PubMed ID: 15245609 [Abstract] [Full Text] [Related]
10. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence. Nakayama M, Sakahara H, Minowa Y, Sasai K, Ishigaki T, Saga T, Nakamoto Y, Yao Z, Hiraoka M, Sakai K, Konishi J. Radiat Med; 1997 Jun 15; 15(2):79-83. PubMed ID: 9192431 [Abstract] [Full Text] [Related]
11. Positron emission tomography scanning in the assessment of patients with lymphoma. Foo SS, Mitchell PL, Berlangieri SU, Smith CL, Scott AM. Intern Med J; 2004 Jul 15; 34(7):388-97. PubMed ID: 15271172 [Abstract] [Full Text] [Related]
12. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Front D, Israel O. Semin Nucl Med; 1995 Jan 15; 25(1):60-71. PubMed ID: 7716559 [Abstract] [Full Text] [Related]
13. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma. Herman M, Paucek B, Raida L, Myslivecek M, Zapletalová J. Eur J Radiol; 2007 Dec 15; 64(3):432-8. PubMed ID: 17478069 [Abstract] [Full Text] [Related]
14. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma. Rehm PK. Cancer Biother Radiopharm; 1999 Aug 15; 14(4):251-62. PubMed ID: 10850311 [Abstract] [Full Text] [Related]
16. [Ga-67 scintigraphy for the localization and staging of malignant lymphoma]. Monzawa S, Karikomi M, Uno K, Itami J, Arimizu N. Gan No Rinsho; 1988 Aug 15; 34(9):1059-64. PubMed ID: 3172511 [Abstract] [Full Text] [Related]
17. Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance? Bar-Shalom R, Israel O, Haim N, Leviov M, Epelbaum R, Frenkel A, Ben-Haim S, Kolodny GM, Front D. Radiology; 1996 May 15; 199(2):473-6. PubMed ID: 8668797 [Abstract] [Full Text] [Related]
18. [Use of Ga-67 SPECT in patients with malignant lymphoma after primary chemotherapy for further treatment planning: comparison with spiral CT]. Stroszczynski C, Amthauer H, Hosten N, Mapara M, Ricke J, Jochens R, Fischer-Funk E, Ludwig WD, Eichstädt H, Felix R. Rofo; 1997 Nov 15; 167(5):458-66. PubMed ID: 9440890 [Abstract] [Full Text] [Related]
19. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma. Zollars LE, Nagel JS, Tumeh SS. J Nucl Med; 1987 Oct 15; 28(10):1611-5. PubMed ID: 3655913 [Abstract] [Full Text] [Related]
20. Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy. Front D, Bar-Shalom R, Mor M, Haim N, Epelbaum R, Frenkel A, Gaitini D, Kolodny GM, Israel O. Radiology; 1999 Feb 15; 210(2):487-91. PubMed ID: 10207434 [Abstract] [Full Text] [Related] Page: [Next] [New Search]